Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Pulmonary Hypertension

Free Subscription 15.12.2025 1 Acta Physiol (Oxf) 1 Am J Respir Cell Mol Biol 1 Animals (Basel) 1 Best Pract Res Clin Rheumatol 1 Biosci Rep 1 BMJ Case Rep 1 Cardiovasc Drugs Ther 1 Case Rep Cardiol 1 Case Rep Pediatr 1 Chest 1 Circ Heart Fail 1 Clin Exp Hypertens 2 ERJ Open Res 1 Eur J Med Res 1 Eur J Pediatr 1 Eur Respir J 1 Front Artif Intell 1 Front Bioeng Biotechnol 1 Heart 1 Int J Pharm 1 J Am Heart Assoc 1 J Am Soc Echocardiogr 1 J Bras Pneumol 1 J Nucl Cardiol 2 J Pak Med Assoc 1 J Thorac Dis 1 JACC Heart Fail 1 Kardiol Pol 1 Lancet Respir Med 1 Medicine (Baltimore) 1 Mitochondrion 1 Naunyn Schmiedebergs Arch Pharmacol 1 Pflugers Arch 1 Pulm Circ 1 Res Dev Disabil 1 Respir Investig 1 Respir Med 1 Respirol Case Rep 1 Reumatol Clin (Engl Ed) 1 Rev Esp Cardiol (Engl Ed) 2 Rheumatology (Oxford) 2 Sci Rep 1 Thorax 1 Tuberc Respir Dis (Seoul) 2 Vascul Pharmacol 1 World J Crit Care Med 1 Zhonghua Jie He He Hu Xi Za Zhi

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Physiol (Oxf)

1. MO Q, Wen X, Wang L, Cao W, et al
   Upregulated Calcium Sensing Receptor Mediates Pulmonary Venous Remodeling in Pulmonary Hypertension.
   Acta Physiol (Oxf). 2026;242:e70142.
   PubMed         Abstract available
   
   

   
   Am J Respir Cell Mol Biol

2. MAGHSOUDI S, Bhatia V, Hinton M, Singh N, et al
   Adenylyl Cyclase Isoform 6 in the Pulmonary Artery Is Inhibited by Hypoxia via Cysteine Nitrosylation.
   Am J Respir Cell Mol Biol. 2025;72:82-96.
   PubMed         Abstract available
   
   

   
   Animals (Basel)

3. VAN RENTERGHEM E, Legrand M, Lekane M, Roels E, et al
   Prognostic Value of Body Weight-Independent Tricuspid Annular Plane Systolic Excursion to Systolic Pulmonary Arterial Pressure Ratio in Canine Precapillary Pulmonary Hypertension: A Retrospective Study.
   Animals (Basel). 2025;15:3365.
   PubMed         Abstract available
   
   

   
   Best Pract Res Clin Rheumatol

4. POPE J
   Novel therapies in SSc.
   Best Pract Res Clin Rheumatol. 2025;39:102104.
   PubMed         Abstract available
   
   

   
   Biosci Rep

5. SINGH K, Kumar G K, Ali M, Choudhary R, et al
   Integrative blood profiling uncovers inflammatory network signatures in high-altitude pulmonary edema.
   Biosci Rep. 2025;45:BSR20253746.
   PubMed         Abstract available
   
   

   
   BMJ Case Rep

6. BERRA G, Genecand L, Juillet A, Deux JF, et al
   Reversible pulmonary hypertension in a patient diagnosed with scurvy.
   BMJ Case Rep. 2025;18:e266143.
   PubMed         Abstract available
   
   

   
   Cardiovasc Drugs Ther

7. PATEL J, Doshi G
   Crosstalk between Ryanodine Receptor 2 Dysfunction and FK506-Binding Proteins in Pulmonary Hypertension.
   Cardiovasc Drugs Ther. 2025 Dec 13. doi: 10.1007/s10557-025-07809.
   PubMed         Abstract available
   
   

   
   Case Rep Cardiol

8. JENA N, Rrapo T, Pahi S, Pradhan J, et al
   Persistent Pulmonary Hypertension in Corrected Congenital Left Circumflex Artery to Coronary Sinus Fistula: A Case Report and Literature Review.
   Case Rep Cardiol. 2025;2025:6985938.
   PubMed         Abstract available
   
   

   
   Case Rep Pediatr

9. FADEL NB, Almoli E, de Nanassy J, Mashally S, et al
   New Insights: P.I.G in Preterm Infants With Isolated PDA and Severe Pulmonary Hypertension.
   Case Rep Pediatr. 2025;2025:6268296.
   PubMed         Abstract available
   
   

   
   Chest

10. KHAN SL, Paoli CJ, Kime N, Williams K, et al
    Treatment patterns in incident pulmonary hypertension patients: real-world data from the Pulmonary Hypertension Association Registry.
    Chest. 2025 Dec 8:S0012-3692(25)05817-9. doi: 10.1016/j.chest.2025.
    PubMed         Abstract available
    
    

    
    Circ Heart Fail

11. AGUADO B, Ruffenach G, Lacoste-Palasset T, Gorlach A, et al
    Use of SGLT2 (Sodium-Glucose Cotransporter 2) Inhibitors in Pulmonary Hypertension.
    Circ Heart Fail. 2025 Dec 5:e013481. doi: 10.1161/CIRCHEARTFAILURE.125.013481.
    PubMed         Abstract available
    
    

    
    Clin Exp Hypertens

12. ZHANG Y, Liu C, Zhou J, Li W, et al
    Iron status mediates the causal effects of high-altitude adaptation signals in the HIF-PHD axis on pulmonary vascular and right-heart outcomes.
    Clin Exp Hypertens. 2025;47:2595152.
    PubMed         Abstract available
    
    

    
    ERJ Open Res

13. HELD M, Pausch C, Huscher D, Pittrow D, et al
    Survival in patients with chronic thromboembolic pulmonary hypertension treated with riociguat versus other medications: a COMPERA analysis.
    ERJ Open Res. 2025;11:00230-2025.
    PubMed         Abstract available
    
    
14. DELCROIX M, Lang IM, D'Armini AM, Fadel E, et al
    Long-term effects of medical treatment in patients with chronic thromboembolic pulmonary hypertension.
    ERJ Open Res. 2025;11:00769-2025.
    PubMed         Abstract available
    
    

    
    Eur J Med Res

15. KRAMER T, Kramer M, Hagist C, Spinler S, et al
    Artificial intelligence in pulmonary hypertension: a systematic review.
    Eur J Med Res. 2025;30:1225.
    PubMed         Abstract available
    
    

    
    Eur J Pediatr

16. AHMED MA, Memon WUS, Ahmed OB
    Comment on: Nebulized nitroglycerin as an adjuvant drug in the management of persistent pulmonary hypertension of the newborn.
    Eur J Pediatr. 2025;185:13.
    PubMed        
    
    

    
    Eur Respir J

17. GRYNBLAT J, Farges M, Magro P, Savale L, et al
    Pulmonary hypertension in patients with Noonan syndrome.
    Eur Respir J. 2025 Dec 11:2501796. doi: 10.1183/13993003.01796-2025.
    PubMed         Abstract available
    
    

    
    Front Artif Intell

18. AHMED F, Haider F, Arham M, Dad A, et al
    Comparative diagnostic accuracy of artificial intelligence-derived risk stratification versus conventional risk stratification methods in pulmonary hypertension patients: a systematic review and meta-analysis.
    Front Artif Intell. 2025;8:1692829.
    PubMed         Abstract available
    
    

    
    Front Bioeng Biotechnol

19. TIAN R, Xu S, Liu C, Wang Y, et al
    Mesenchymal stem cell therapy for pulmonary hypertension: an update.
    Front Bioeng Biotechnol. 2025;13:1692396.
    PubMed         Abstract available
    
    

    
    Heart

20. MULLER J, Mayer L, Schneider SR, Bauer M, et al
    Pulmonary haemodynamics and right heart function during exercise at high versus low altitude in patients with pulmonary vascular disease: a randomised crossover trial.
    Heart. 2025;112:28-36.
    PubMed         Abstract available
    
    

    
    Int J Pharm

21. ALI MS, Elhabak M, Ibrahim SS, Elmowafy E, et al
    Breath-activated nanomedicine: Ambrisentan-loaded chitosomes for pulmonary arterial hypertension.
    Int J Pharm. 2026;687:126370.
    PubMed         Abstract available
    
    

    
    J Am Heart Assoc

22. RUAN B, Chen M, Zhuang Q, Guan L, et al
    Chest Computed Tomography-Based Radiomics for the Diagnosis and Prognosis of Pulmonary Hypertension.
    J Am Heart Assoc. 2025 Dec 11:e043221. doi: 10.1161/JAHA.125.043221.
    PubMed         Abstract available
    
    

    
    J Am Soc Echocardiogr

23. EGBE AC, Reddy YNV, Pellikka PA, Borlaug BA, et al
    Impaired Pulmonary Vascular Reserve in Adults with Repaired Coarctation of Aorta: Prevalence, Correlates, and Association with Disease Severity.
    J Am Soc Echocardiogr. 2025;38:1179-1188.
    PubMed         Abstract available
    
    

    
    J Bras Pneumol

24. SALIBE-FILHO W, Vieira TM, Leonidas Alves-Junior J, Nascimento YPP, et al
    Upfront combination therapy with sildenafil and ambrisentan in patients with chronic thromboembolic pulmonary hypertension.
    J Bras Pneumol. 2025;51:e20250056.
    PubMed         Abstract available
    
    

    
    J Nucl Cardiol

25. WANG K, Li X, Song S, Li H, et al
    Quantifying Right Ventricular Fibrosis Burden in CTEPH via FAPI SPECT/CT: Correlation with Echocardiographic Parameters and BPA Response.
    J Nucl Cardiol. 2025 Nov 20:102565. doi: 10.1016/j.nuclcard.2025.102565.
    PubMed         Abstract available
    
    

    
    J Pak Med Assoc

26. MUSHTAQ MS, Gul H, Draz MU, Khan M, et al
    Comparison between clinical and immunological features of scleroderma with and without interstitial lung disease.
    J Pak Med Assoc. 2025;75:1445-1449.
    PubMed         Abstract available
    
    
27. NAYYAB I, Bashir H, Shahbaz H
    Incidental finding of antiphospholipid antibody syndrome in a patient with Cor Pulmonale: A case report.
    J Pak Med Assoc. 2025;75:1453-1455.
    PubMed         Abstract available
    
    

    
    J Thorac Dis

28. 
    Erratum: Integrative bioinformatics approach for identifying key genes and potential therapeutic targets in the concurrent manifestation of hypertrophic cardiomyopathy and pulmonary hypertension.
    J Thorac Dis. 2025;17:10589.
    PubMed         Abstract available
    
    

    
    JACC Heart Fail

29. LAMBERTI K, Grinstein J
    Practical Application of Pressure-Volume Loops and Cardiac Energetics to Improve Care Delivery in Pulmonary Hypertension: Have We Finally Found the "RIGHT" Toolbox?
    JACC Heart Fail. 2025 Dec 5:102781. doi: 10.1016/j.jchf.2025.102781.
    PubMed        
    
    

    
    Kardiol Pol

30. PLAZAK W, Bernhardt AM
    Pulmonary hypertension in heart failure patients in the modern era of mechanical circulatory support.
    Kardiol Pol. 2025;83:1259-1267.
    PubMed         Abstract available
    
    

    
    Lancet Respir Med

31. KIM NH, Delcroix M, Pepke-Zaba J
    To thin, or not too thin: questions of anticoagulation for pulmonary hypertension.
    Lancet Respir Med. 2025 Dec 8:S2213-2600(25)00373.
    PubMed        
    
    

    
    Medicine (Baltimore)

32. LI Y, Bin N, Zhou J, Jiang L, et al
    Trends and projections of the global burden of pulmonary arterial hypertension (1990-2050): An observational trend study.
    Medicine (Baltimore). 2025;104:e46448.
    PubMed         Abstract available
    
    

    
    Mitochondrion

33. CHATURVEDI G, Dubey N, Panchbhai P, Singh S, et al
    Mitochondrial-ER crosstalk: An emerging mechanism in the pathophysiology of pulmonary arterial hypertension.
    Mitochondrion. 2026;86:102094.
    PubMed         Abstract available
    
    

    
    Naunyn Schmiedebergs Arch Pharmacol

34. SHALABI L, Tabassum S, Al Zoubi BM, Taha HI, et al
    Efficacy and safety of sotatercept in pulmonary arterial hypertension: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis.
    Naunyn Schmiedebergs Arch Pharmacol. 2025;398:16767-16778.
    PubMed         Abstract available
    
    

    
    Pflugers Arch

35. COSTA SFF, Leite LB, Soares LL, Dos Lucio Generoso SC, et al
    Resistance exercise training attenuates skeletal muscle atrophy in experimental pulmonary arterial hypertension.
    Pflugers Arch. 2025;478:3.
    PubMed         Abstract available
    
    

    
    Pulm Circ

36. ABOFREKHA B, Jdaidani J, Shadi M, Sanayeh EB, et al
    Improvement in Right Ventricular Function and Pulmonary Pressures in Patients With Severe Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction Treated With Sacubitril-Valsartan.
    Pulm Circ. 2025;15:e70217.
    PubMed         Abstract available
    
    

    
    Res Dev Disabil

37. YIN C, Deng C, Crespi CM, Bar S, et al
    The relation between Down syndrome and co-occurring conditions in children and young adults: A population-based cohort in Denmark, 1977-2016.
    Res Dev Disabil. 2025;167:105167.
    PubMed         Abstract available
    
    

    
    Respir Investig

38. SHOMURA T, Wada Y, Goto N, Suzuki Y, et al
    Impact of bendopnea on indicators of pulmonary hypertension, health-related quality of life, and pulmonary function in patients with chronic obstructive pulmonary disease.
    Respir Investig. 2025;64:101346.
    PubMed         Abstract available
    
    

    
    Respir Med

39. ESTRADA RA, Baher H, Andrade L, Zabelny K, et al
    Vaccination utilization in patients with pulmonary hypertension.
    Respir Med. 2025;251:108549.
    PubMed         Abstract available
    
    

    
    Respirol Case Rep

40. ALABSI AT, Yusuf KA, Aldoseri AS, Kanhosh SF, et al
    A Case of Right-Sided Heart Failure and Severe Pulmonary Hypertension Secondary to Partial Anomalous Pulmonary Venous Connection.
    Respirol Case Rep. 2025;13:e70438.
    PubMed         Abstract available
    
    

    
    Reumatol Clin (Engl Ed)

41. KOOHI A, Rashidi F, Attaran D, Mirfeizi Z, et al
    Incidence of pulmonary hypertension in patients with Takayasu's arteritis: A transthoracic echocardiographic evaluation.
    Reumatol Clin (Engl Ed). 2025;21:501994.
    PubMed         Abstract available
    
    

    
    Rev Esp Cardiol (Engl Ed)

42. BAEZ-FERRER N, Abril-Pla M, Al-Hayani-Al-Hantoosh AW, Avanzas P, et al
    Prognostic significance of combined pulmonary hypertension in mitral regurgitation surgery.
    Rev Esp Cardiol (Engl Ed). 2025 Dec 4:S1885-5857(25)00347.
    PubMed        
    
    

    
    Rheumatology (Oxford)

43. RUSCITTI P, Vitale A, Di Cola I, Caggiano V, et al
    The clinical assessment of lung involvement in patients with Still's disease, results from the multicentre international AIDA Network Still's Disease Registry.
    Rheumatology (Oxford). 2025;64.
    PubMed         Abstract available
    
    
44. COGHLAN JG
    DETECTing pulmonary hypertension in patients with emphysema & systemic sclerosis: Can we? Should we?
    Rheumatology (Oxford). 2025 Dec 13:keaf671. doi: 10.1093.
    PubMed        
    
    

    
    Sci Rep

45. SHIMIZU D, Goda A, Tashiro S, Tobita K, et al
    Association of bioelectrical impedance phase angle with exercise tolerance in patients with chronic thromboembolic pulmonary hypertension.
    Sci Rep. 2025 Dec 8. doi: 10.1038/s41598-025-27925.
    PubMed        
    
    
46. GONG C, Lan X, Xie Y, Wu X, et al
    Overexpression of PRDX2 alleviates chronic thromboembolic pulmonary hypertension by modulating inflammation and mitophagy.
    Sci Rep. 2025 Dec 10. doi: 10.1038/s41598-025-31063.
    PubMed         Abstract available
    
    

    
    Thorax

47. TAYLOR JC, Knowlton KU, Wilson TC, Dodson MW, et al
    Recurrent right atrial myxoma presenting as pulmonary hypertension and peripheral pulmonary artery aneurysms.
    Thorax. 2025 Dec 10:thorax-2025-223625. doi: 10.1136/thorax-2025-223625.
    PubMed        
    
    

    
    Tuberc Respir Dis (Seoul)

48. LEE I, Joh JS, Lee JY, Kim J, et al
    Clinical outcome prediction by high-resolution computed tomography and echocardiography assessment of pulmonary hypertension in patients with bronchiectasis.
    Tuberc Respir Dis (Seoul). 2025 Dec 9. doi: 10.4046/trd.2025.0067.
    PubMed         Abstract available
    
    

    
    Vascul Pharmacol

49. HATA A, Gur B, Kalra J, Prabhakar A, et al
    Pulmonary veno-occlusive disease: Insights from animal models.
    Vascul Pharmacol. 2025;161:107547.
    PubMed         Abstract available
    
    
50. LONG C, Lin M, Wang W, Liu Y, et al
    RNA-seq and ChIP-seq reveal microplastics induce endothelial-mesenchymal transition via HK2-mediated histone lactylation in pulmonary hypertension.
    Vascul Pharmacol. 2025;162:107571.
    PubMed         Abstract available
    
    

    
    World J Crit Care Med

51. ALI W, Ur Rab A, Shaikh A, Anil G, et al
    Palliative care in pulmonary hypertension: A systematic review and meta-analysis.
    World J Crit Care Med. 2025;14:110597.
    PubMed         Abstract available
    
    

    
    Zhonghua Jie He He Hu Xi Za Zhi

52. QI LQ, Xue ZF, Liu XS
    [Research advances on mitochondria-associated endoplasmic reticulum membrane in pulmonary hypertension].
    Zhonghua Jie He He Hu Xi Za Zhi. 2025;48:1196-1202.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge.